15:27 1. When the regime flips, score capex prints on free cash flow — a raise is now a negative catalyst
The repeatable method
- Establish what the market currently rewards. "A year ago… when companies raised their CapEx budgets, the market cheered." Write down the current rule before analyzing any single print — the same fact gets paid differently in different regimes.
- For every capex-heavy name, go past revenue and EPS to free cash flow: cash from operations minus capital spending. Negative FCF means growth is being funded off the balance sheet, not out of profits.
- Combine the two: in a regime that has stopped cheering spend, a raised capex budget plus negative FCF is the sell trigger — regardless of how good the revenue line is.
- Re-test the regime each quarter by watching stock reactions, not narratives: which facts are being paid for, and which are being punished.
Here: GOOGL grew revenue 24% (cloud +82%) but posted FCF of −$5.9B and lifted 2026 AI capex $190B→$205B — "the market is beginning to lose patience with all this crazy spending" — −7%. TSLA pushed capex to $5.8B, went FCF-negative (−$1.1B) "for the first time in 2 years" — −14.5%. Nasdaq −2%+ on the pair.
Watch for
- FCF crossing into negative on a company that has always self-funded; a capex guide raised mid-year; a strong revenue print sold off anyway; management framing spend as "investment" without an ROI metric.
8:33 2. For a long-cycle business, orders and backlog are the metric — not quarterly EPS
The repeatable method
- First classify the business: if the product is delivered years after it's sold (turbines, aircraft, defense systems), quarterly EPS reflects deliveries booked long ago — "this is a very long-tail business."
- Grade it on new orders (the fresh demand signal) and backlog (contracted future revenue), and note the backlog's rate of change, not just its level.
- Treat an EPS miss or a light guidance raise on such a name as noise unless orders also deteriorate: "I don't think that most investors are focused on the EPS miss. The most important metric is orders."
- Separately, discount "whisper numbers" — a raise can be objectively good and still disappoint an unpublished expectation; that's a sentiment event, not a business event.
Here: GEV missed on EPS 247 (+33%) and raised below whispers, so the stock fell — but orders were +88% to $24.2B and backlog $176B: "I still own the stock… I remain confident." Same lens on defense: LMT's record $230B backlog "up 24% in 3 months" and NOC's record $105B.
Watch for
- Order growth decelerating while backlog still looks large; backlog concentrated in one customer; a stock reaction driven by whisper numbers rather than the reported set.
11:01 3. Take investment gains out of reported EPS before you judge the quarter
The repeatable method
- Check whether reported earnings include gains on investment stakes, marks on holdings, or other non-operating items. "Google had massive gains on its investments, which it reported as part of earnings per share. So, I take that out."
- Recompute the comparison on the adjusted basis, against both last year and consensus — a beat can invert into a miss once the non-operating line is removed.
- Then judge the operating business separately (here: revenue +24%, cloud +82% — genuinely good) so you know which part of the print is durable.
Here: GOOGL's adjusted EPS was 285 vs 231 last year but below the 289 expected — a miss the headline number hid, before the negative-FCF problem even enters.
Watch for
- "Other income" swinging quarter to quarter; large corporate venture/equity portfolios; companies that mark private stakes through the P&L; EPS beats that don't show up in cash flow.
3:59 4. For a consumer-facing name, same-store sales is the truth serum
The repeatable method
- Ignore the headline beat/miss first and pull same-store sales — growth from stores open a year or more — because it strips out new openings and price-only revenue. It "is the best indication of growth for a consumer-facing company."
- Compare it to its own recent trend, not to consensus: a five-quarter low is a trajectory statement even if the quarter beat.
- Use a value/low-ticket brand as the read on the bottom half of a K-shaped economy, and discount any pop driven by a revenue beat that same-store sales contradicts.
Here: DPZ's EPS turned from −5% to +7% and revenue beat, taking the stock +2% Monday — but same-store sales grew just 0.1%, "its lowest pace in five quarters," and it "gave back all of its gains plus." "A poster child for the K-shaped economy," −20% YTD.
Watch for
- Same-store sales decelerating while total revenue grows on unit expansion; traffic negative with pricing positive; a value brand's comps rolling over while premium peers hold.
13:41 5. Identify the ruling narrative — inside it, good results stop mattering and there's "no room for error"
The repeatable method
- Ask what story currently owns the sector (here the "SaaSpocalypse" — AI eats business software). A ruling narrative changes the payoff of results, not the results.
- Separate the two questions explicitly: is the business deteriorating, and is the stock being marked down anyway? "ServiceNow has executed really well… shows no signs that AI is negatively impacting its businesses" — and fell 4%. "Fighting the AI narrative is like fighting a ghost."
- Inside a ruling narrative, treat any small stumble as fully priced against you: "because of the SaaSpocalypse, there is no room for error" — and legitimate explanations don't help, because "no one is interested in excuses."
- So separate the business call from the timing call: own the narrative victim only if you can wait for the narrative to expire, and avoid narrative names that still have guidance risk.
Here: NOW — EPS +10%, revenue +24%, "I don't see any weaknesses in these numbers" — down 38% YTD and −4% on the print. EFX — the Workforce Solutions division is "a software business," so a mid-single-digit government revenue decline against flat guidance plus a 3%-light EPS guide took another 4% off a stock already −17% YTD.
Watch for
- Clean numbers meeting a falling stock; sell-side questions all about the narrative rather than the P&L; guidance trimmed for a real, explainable reason and punished anyway; the first quarter where the narrative does show up in the numbers.
16:37 6. Discount a supplier's blowout — it's the arithmetic of its customers' budgets, not new information
The repeatable method
- Before treating a strong supplier print as evidence the theme is healthy, ask whether it was already implied by the buyers' announced budgets: "given CapEx budgets, it would be surprising if Intel did not have a good quarter."
- Locate the actual open question in the chain. If the doubt is about the spenders' ability or willingness to keep spending, a supplier beat can't answer it — "it's the AI CapEx budgets themselves that are making investors nervous."
- Look one step upstream for the falsifying evidence (the customers' cash flows and guidance), and don't let a downstream beat reset your view.
Here: INTC posted 42c vs a 10c loss, the best revenue growth in 15 years and data-center sales +59% — and Eisman still says the print "won't quell AI nervousness," because the doubt lives at GOOGL/TSLA-style cash flows, not at the chipmakers' order books.
Watch for
- Supplier results that merely confirm published customer budgets; the gap between supplier strength and customer FCF widening; a customer trimming capex after the supplier has already guided up.
18:48 7. Before buying a "diversifier," trace its earnings driver — it may be the same trade in disguise
The repeatable method
- For any name bought to diversify away from your dominant exposure, decompose why it is earning well right now — not what sector it sits in.
- Follow the revenue to its source. Bank profits currently lean on an investment-banking cycle "heavily dependent on AI financing needs" — the underwriting of AI debt and equity — so the diversifier is levered to the same driver.
- Check valuation on top of that: "after experiencing a great run, they are at peak valuations" — a correlated position bought at peak multiples is the worst version of the trade.
- Conclusion test: if the hedge and the core position share one failure mode, it isn't a hedge. "Buying banks to me does not provide diversification from tech."
Here: he owns no banks — "owning MS, GS, BAC, C, etc. is just one more aspect of the AI trade." And the trust banks (BK, STT) are a category he doesn't follow: BK is +30% this year, "but you could get the same performance by buying just about any other of the large cap banks" — no differentiated edge.
Watch for
- A "cheap diversifier" whose earnings driver traces back to your main theme; peak-cycle valuations in the hedge; sector labels doing the diversification work instead of cash-flow analysis.
3:10 8. A credible cheap substitute converts "no moat" into a priced price war
The repeatable method
- Keep the risks to a capital-intensive theme as an explicit list and note which are still theoretical: "prior to last week, we were worried about AI capital intensity and the lack of moats."
- Treat the arrival of a credible cheaper substitute as the event that promotes "no moat" from a structural worry to a near-term earnings risk — "now, the possibility of a price war looms closer."
- Test the claim's credibility (parity at a fraction of the cost) and the switching cost for customers; where switching is easy, price is the only defense left.
- Re-underwrite the spenders, not the substitute: the committed capex stays fixed while the revenue it was built to earn gets repriced down.
Here: Moonshot's Kimi K3 is claimed "as good as any LLM out there, but for a fraction of the cost" — the third leg (price war) added to capital intensity and no moats, and part of why "everyone is nervous" as GOOGL raises its budget again.
Watch for
- A challenger claiming parity at a fraction of the price; customers running pilots on the cheap alternative; incumbents cutting list prices or bundling; capex commitments that can't be scaled back.
19:29 9. Use a funding short — finance a high-conviction long with a low-conviction short
The repeatable method
- Understand the mechanics first: borrow a share, sell it (say at $100), and you hold $100 cash plus an obligation to return the share. Buy it back lower ($50) and the gain is the difference "less the fee you pay for borrowing the stock."
- The funding variant: pick a name you expect to go roughly nowhere — "not going to do that much" — and short it purely to raise the cash.
- Deploy that cash into the long you actually want: "essentially, I'm using the short to fund a long in a different stock. I'm hoping to make a lot of money on the long and either break even or make a little on the short."
- Underwrite the short as a funding cost, not a profit centre: the tolerable outcome is flat, so screen for low borrow fees, low short-squeeze risk and no catalyst that could rip it higher.
Here: answering Colin's mailbag on why hedge funds short payments stocks as funding shorts (a point from the Ken Suchoski premium episode) — the payments group is the low-expectation name that finances the position they want elsewhere.
Watch for
- Borrow cost eating the funding benefit; a "dead money" short with an unexpected catalyst; correlation between the funding short and the long (both fall together and the structure adds no capital).
18:04 10. Separate the thesis from the management — a right idea with the wrong operator still loses
The repeatable method
- When the thesis is a turnaround, underwrite the operator as a distinct variable: can this management execute the specific change you are paying for?
- Use repeated control failures — not one bad quarter — as the exit trigger; a pattern ("its umpteenth trading scandal") says the institution, not the cycle, is the problem.
- When you exit on management rather than thesis, immediately look for the same thesis at a better-run competitor: "I should have bought an alternative."
- And respect your own circle: he stayed in tech because that's where his research time is spent — "which has proven to be a pretty good decision."
Here: C — he owned Citigroup pre-Jane Fraser and sold after another trading scandal: "I had the right thesis, but the wrong management." He also flags an upcoming masterclass on how to analyze and value banks.
Watch for
- Recurring risk/control failures at the same firm; a turnaround thesis surviving multiple CEOs; a better-run peer offering the same exposure; the temptation to hold because the idea was right.